The percentage of individuals >=18 years of age with concurrent use of prescription opioids and benzodiazepines during the measurement year.
A lower rate indicates better performance.
- Measure TypeElectronic Clinical Quality Measure (eCQM)Level Of AnalysisData dictionary not attachedNoNumerator
The number of individuals from the denominator with concurrent use of opioids and benzodiazepines for >=30 cumulative days during the measurement year.
DenominatorThe denominator includes individuals >=18 years of age with >=2 prescription claims for opioid medications on different dates of service and with >=15 cumulative days’ supply during the measurement year. Individuals with cancer, sickle cell disease, or in hospice are excluded.
ExclusionsIndividuals with cancer, sickle cell disease, or in hospice at any point during the measurement year are excluded from the denominator.
All information required to stratify the measure resultsOffAll information required to stratify the measure resultsOffTesting Data Sources
- Measure StructureMeasure Selection AttributesNational Quality Strategy PrioritiesAffordable CareOveruse/Waste
- Risk AdjustmentRisk adjustment approachOffRisk adjustment approachOffConceptual model for risk adjustmentOffConceptual model for risk adjustmentOff
- Current or planned use(s)Current Use(s)
- Most Recent Endorsement ActivityEndorsed Patient Safety Spring Cycle 2021Initial EndorsementNext Planned Maintenance ReviewPatient Safety Spring 2025Endorsement StatusLast Updated
- Do you have a secondary measure developer point of contact?OffThe measure developer is NOT the same as measure stewardOnStewardSteward Organization EmailSteward Phone NumberSteward Organization URLSteward Organization Copyright
COPYRIGHT 2021 PQA, INC. ALL RIGHTS RESERVED
- Detailed Measure SpecificationsNoLogic ModelOffImpact and GapNoFeasibility assessment methodology and resultsNoAddress health equityNoMeasure’s use or intended useNo508 ComplianceOff